Table 3.
The top 5 predictions computed by TPGLDA for Lung Cancer, Hepatocellular Carcinoma and Ovarian Cancer and the confirmation for their associations by related databases.
| LncRNA | TPGLDA’s rank | Evidences (PMID) | Description |
|---|---|---|---|
| Lung Cancer | |||
| GAS5 | 1 | 25925741,24357161 | Lnc2Cancer,LncRNA2Target |
| CDKN2B-AS1 | 2 | 21489289,26408699 | MNDR,Lnc2Cancer |
| UCA1 | 3 | 26380024 | Lnc2Cancer |
| PVT1 | 4 | 26493997;26493997 | Lnc2Cancer,literature |
| HNF1A-AS1 | 5 | 25863539 | literature |
| Hepatocelluar Carcinoma | |||
| GAS5 | 1 | 26404135, 26163879 | Lnc2Cancer, literature |
| SOX2-OT | 2 | 26097588 | Lnc2Cancer |
| PVT1 | 3 | 25624916 | Lnc2Cancer |
| LINC00152 | 4 | 27351280, 26356260 | Lnc2Cancer, literature |
| UCA1 | 5 | 27215316, 27167190 | Lnc2Cancer, literature |
| Ovarian Cancer | |||
| MEG3 | 1 | 24859196 | Lnc2Cancer,LncRNA2Target |
| GAS5 | 2 | 26503132 | Lnc2Cancer |
| CCAT2 | 3 | 27283598 | Lnc2Cancer |
| BANCR | 4 | unconfirmed | unconfirmed |
| CDKN2B-AS1 | 5 | 27095571 | Lnc2Cancer |